| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11684-018-0631-2 |
| P698 | PubMed publication ID | 29934743 |
| P50 | author | Ali A Rabaan | Q87010484 |
| P2860 | cites work | Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial | Q40295575 |
| Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh | Q40371673 | ||
| IncA/C plasmids harboured in serious multidrug-resistant Vibrio cholerae serogroup O139 strains in China | Q41586714 | ||
| Detection of Vibrio cholerae O1 and O139 in environmental waters of rural Bangladesh: a flow-cytometry-based field trial | Q41605235 | ||
| Cholera - the new strike of an old foe. | Q41929540 | ||
| Multidrug-Resistant Vibrio cholerae O1 was Responsible for a Cholera Outbreak in 2013 in Bagalkot, North Karnataka. | Q42155311 | ||
| Emergence and spread of tetracycline resistant Vibrio cholerae O1 El Tor variant during 2010 cholera epidemic in the tribal areas of Odisha, India | Q42176127 | ||
| Toxigenic Vibrio cholerae identified in estuaries of Tanzania using PCR techniques | Q42176323 | ||
| Survivability and molecular variation in Vibrio cholerae from epidemic sites in China | Q42223057 | ||
| Comparative analysis of different oral approaches to treat Vibrio cholerae infection in adult mice | Q42229799 | ||
| Regulation, replication, and integration functions of the Vibrio cholerae CTXphi are encoded by region RS2. | Q42660232 | ||
| Cholera in the United States, 1995-2000: trends at the end of the twentieth century | Q43560902 | ||
| Efficacy of cocktail phage therapy in treating Vibrio cholerae infection in rabbit model | Q43676844 | ||
| SXT-related integrating conjugative element and IncC plasmids in Vibrio cholerae O1 strains in Eastern Africa. | Q43943588 | ||
| Genetic determinants of virulence, antibiogram and altered biotype among the Vibrio cholerae O1 isolates from different cholera outbreaks in India. | Q44450687 | ||
| Pathogenic potential of vibriophages against an experimental infection with Vibrio cholerae O1 in the RITARD model | Q44868362 | ||
| Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins. | Q51313072 | ||
| Considerations around the introduction of a cholera vaccine in Bangladesh. | Q51732904 | ||
| Evidence for TLR4 and FcRγ-CARD9 activation by cholera toxin B subunit and its direct bindings to TREM2 and LMIR5 receptors. | Q52940284 | ||
| 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. | Q53311743 | ||
| Occurrence and composition of class 1 and class 2 integrons in clinical and environmental O1 and non-O1/non-O139 Vibrio cholerae strains from the Brazilian Amazon. | Q54430443 | ||
| Cholera | Q57119004 | ||
| Small chromosomal integration site of classical CTX prophage in Mozambique Vibrio cholerae O1 biotype El Tor strain | Q62487162 | ||
| Additional serovars and inter-O antigenic relationships of Vibrio cholerae | Q67054283 | ||
| Serovars of Vibrio cholerae identified during 1970-1975 | Q67054285 | ||
| Isolation of nonagglutinable vibrios from an enteritis outbreak in Czechoslovakia | Q72028021 | ||
| Evidence for a rolling-circle mechanism of phage DNA synthesis from both replicative and integrated forms of CTXphi | Q74319615 | ||
| Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response | Q84066281 | ||
| Antimicrobial drugs for treating cholera | Q24193884 | ||
| CTXphi infection of Vibrio cholerae requires the tolQRA gene products | Q24548978 | ||
| Regulatory cascade controls virulence in Vibrio cholerae | Q24564679 | ||
| Molecular tools in understanding the evolution of Vibrio cholerae | Q26779244 | ||
| Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virus | Q27468627 | ||
| Structure of Vibrio cholerae ToxT reveals a mechanism for fatty acid regulation of virulence genes | Q27659552 | ||
| Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities | Q28246089 | ||
| Suppression of Virulence of Toxigenic Vibrio cholerae by Anethole through the Cyclic AMP (cAMP)-cAMP Receptor Protein Signaling System | Q28547913 | ||
| Strategies to Prevent Cholera Introduction during International Personnel Deployments: A Computational Modeling Analysis Based on the 2010 Haiti Outbreak | Q28552894 | ||
| Assessment of the response to cholera outbreaks in two districts in Ghana | Q28596650 | ||
| Understanding the Cholera Epidemic, Haiti | Q29110476 | ||
| LexA cleavage is required for CTX prophage induction | Q29346613 | ||
| Improving immunization approaches to cholera | Q30151668 | ||
| Adapting to the global shortage of cholera vaccines: targeted single dose cholera vaccine in response to an outbreak in South Sudan | Q30238897 | ||
| Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. | Q30329522 | ||
| New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh | Q30331626 | ||
| Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. | Q30349996 | ||
| Dynamics in genome evolution of Vibrio cholerae. | Q30358315 | ||
| Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophage. | Q30360447 | ||
| Acquisition and evolution of SXT-R391 integrative conjugative elements in the seventh-pandemic Vibrio cholerae lineage. | Q30365868 | ||
| Genomic epidemiology of the Haitian cholera outbreak: a single introduction followed by rapid, extensive, and continued spread characterized the onset of the epidemic. | Q30368395 | ||
| Epidemic waves of cholera in the last two decades in Mozambique. | Q30376314 | ||
| Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014. | Q30381317 | ||
| Variations in SXT elements in epidemic Vibrio cholerae O1 El Tor strains in China. | Q30385406 | ||
| In Silico Screening of Antibacterial Compounds from Herbal Sources Against Vibrio cholerae. | Q30386070 | ||
| Phenotypic Analysis Reveals that the 2010 Haiti Cholera Epidemic Is Linked to a Hypervirulent Strain | Q30389247 | ||
| IncA/C Conjugative Plasmids Mobilize a New Family of Multidrug Resistance Islands in Clinical Vibrio cholerae Non-O1/Non-O139 Isolates from Haiti | Q30390741 | ||
| Sequences of a co-existing SXT element, a chromosomal integron (CI) and an IncA/C plasmid and their roles in multidrug resistance in a Vibrio cholerae O1 El Tor strain | Q30391140 | ||
| Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand | Q30397700 | ||
| Genetic Characterization of Vibrio cholerae O1 isolates from outbreaks between 2011 and 2015 in Tanzania | Q30398904 | ||
| Evidence for several waves of global transmission in the seventh cholera pandemic | Q30406370 | ||
| DBDiaSNP: An Open-Source Knowledgebase of Genetic Polymorphisms and Resistance Genes Related to Diarrheal Pathogens | Q30487954 | ||
| Ribavirin suppresses bacterial virulence by targeting LysR-type transcriptional regulators | Q30832528 | ||
| Epidemiology, determinants and dynamics of cholera in Pakistan: gaps and prospects for future research | Q30870330 | ||
| The 2010 cholera outbreak in Haiti: how science solved a controversy | Q31157564 | ||
| Comparative ICE genomics: insights into the evolution of the SXT/R391 family of ICEs | Q33521306 | ||
| Molecular keys of the tropism of integration of the cholera toxin phage | Q33732696 | ||
| ICEVchInd5 is prevalent in epidemic Vibrio cholerae O1 El Tor strains isolated in India | Q33806542 | ||
| Complete Genome Sequence of Lytic Bacteriophage VPUSM 8 against O1 El Tor Inaba Vibrio cholerae | Q33815295 | ||
| Safety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India. | Q33830466 | ||
| Lysogenic conversion by a filamentous phage encoding cholera toxin | Q34062735 | ||
| Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide | Q34403586 | ||
| Relationship between Distinct African Cholera Epidemics Revealed via MLVA Haplotyping of 337 Vibrio cholerae Isolates | Q34482354 | ||
| A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mic | Q34484003 | ||
| Mortality Rates during Cholera Epidemic, Haiti, 2010-2011. | Q34514555 | ||
| Cross-Border Cholera Outbreaks in Sub-Saharan Africa, the Mystery behind the Silent Illness: What Needs to Be Done? | Q34529519 | ||
| Comparison between Single Dose Azithromycin and Six Doses, 3 Day Norfloxacin for Treatment of Cholera in Adult | Q34903163 | ||
| Antimicrobials & cholera: are we stranded? | Q34943239 | ||
| Environmental surveillance for toxigenic Vibrio cholerae in surface waters of Haiti | Q35140530 | ||
| Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone. | Q35170821 | ||
| Population genetics of Vibrio cholerae from Nepal in 2010: evidence on the origin of the Haitian outbreak | Q35187011 | ||
| Geographic distribution and mortality risk factors during the cholera outbreak in a rural region of Haiti, 2010-2011. | Q35219440 | ||
| Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis | Q35261144 | ||
| Increased isolation frequency of toxigenic Vibrio cholerae O1 from environmental monitoring sites in Haiti | Q35324845 | ||
| Can chatter between microbes prevent cholera? | Q35483390 | ||
| A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. | Q35609627 | ||
| CTXφ Replication Depends on the Histone-Like HU Protein and the UvrD Helicase | Q35636101 | ||
| Updated global burden of cholera in endemic countries | Q35652824 | ||
| Satellite Based Assessment of Hydroclimatic Conditions Related to Cholera in Zimbabwe | Q35791514 | ||
| Assessing the risk factors of cholera epidemic in the Buea Health District of Cameroon | Q35844341 | ||
| Sulphated Polysaccharide Isolated from the Seaweed Gracilaria caudata Exerts an Antidiarrhoeal Effect in Rodents | Q35845903 | ||
| Comparative genomics of Vibrio cholerae from Haiti, Asia, and Africa | Q35847274 | ||
| High-Resolution Crystal Structures Elucidate the Molecular Basis of Cholera Blood Group Dependence | Q35991196 | ||
| Optimal allocation of the limited oral cholera vaccine supply between endemic and epidemic settings | Q36187863 | ||
| Cholera in the United States, 2001-2011: a reflection of patterns of global epidemiology and travel | Q36191192 | ||
| Cholera in Cameroon, 2000-2012: Spatial and Temporal Analysis at the Operational (Health District) and Sub Climate Levels | Q36195017 | ||
| Conjugated Linoleic Acid Reduces Cholera Toxin Production In Vitro and In Vivo by Inhibiting Vibrio cholerae ToxT Activity. | Q36290827 | ||
| Epidemiology of cholera outbreaks and socio-economic characteristics of the communities in the fishing villages of Uganda: 2011-2015. | Q36306115 | ||
| Regulatory networks controlling Vibrio cholerae virulence gene expression | Q36313974 | ||
| Effectiveness of Oral Cholera Vaccine in Haiti: 37-Month Follow-Up | Q36869585 | ||
| Vibrio cholerae: cholera toxin | Q36918438 | ||
| Use of oral cholera vaccine in Haiti: a rural demonstration project | Q37225734 | ||
| Cholera vaccination in urban Haiti | Q37225765 | ||
| Reduced Susceptibility to Extended-Spectrum β-Lactams in Vibrio cholerae Isolated in Bangladesh | Q37345941 | ||
| Antimicrobial Susceptibility of Autochthonous Aquatic Vibrio cholerae in Haiti | Q37355150 | ||
| Phenotypic and antibiogram pattern of V. cholerae isolates from a tertiary care hospital in Mumbai during 2004-2013: a retrospective cross-sectional study | Q37516769 | ||
| A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models | Q37630322 | ||
| Vibrio cholerae O1 with Reduced Susceptibility to Ciprofloxacin and Azithromycin Isolated from a Rural Coastal Area of Bangladesh | Q37653719 | ||
| Safety and immunogenicity assessment of an oral cholera vaccine through phase I clinical trial in Korea | Q37710341 | ||
| A new class of inhibitors of the AraC family virulence regulator Vibrio cholerae ToxT. | Q37717323 | ||
| GM1 Ganglioside: Past Studies and Future Potential. | Q38374343 | ||
| Transmission dynamics of cholera in Yemen, 2017: a real time forecasting | Q38651428 | ||
| A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines | Q38888446 | ||
| Geographical diversity in seasonality of major diarrhoeal pathogens in Bangladesh observed between 2010 and 2012. | Q38962518 | ||
| Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh | Q38978824 | ||
| Genetic relatedness of selected clinical Vibrio cholerae O139 isolates from the southern coastal area of China over a 20-year period | Q39174491 | ||
| Vibrio cholerae O1 Ogawa El Tor strains with the ctxB7 allele driving cholera outbreaks in south-western India in 2012. | Q39207060 | ||
| Genetic characterization of ØVC8 lytic phage for Vibrio cholerae O1. | Q39323730 | ||
| The cholera outbreak in Haiti: where and how did it begin? | Q39414624 | ||
| Effectiveness of mass oral cholera vaccination in Beira, Mozambique | Q39708620 | ||
| Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. | Q39708963 | ||
| The "first" case of cholera in Haiti: lessons for global health | Q40017276 | ||
| Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study | Q40061329 | ||
| Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand. | Q40131955 | ||
| Risk factors for cholera transmission in Haiti during inter-peak periods: insights to improve current control strategies from two case-control studies | Q40142799 | ||
| Effect of Dietary Minerals on Virulence Attributes of Vibrio cholerae | Q40185511 | ||
| Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine | Q40217245 | ||
| Treatment with Entinostat Heals Experimental Cholera by Affecting Physical and Chemical Barrier Functions of Intestinal Epithelia | Q40239307 | ||
| P433 | issue | 2 | |
| P921 | main subject | Yemen | Q805 |
| P304 | page(s) | 213-228 | |
| P577 | publication date | 2018-06-22 | |
| P1433 | published in | Frontiers of medicine | Q26867043 |
| P1476 | title | Cholera: an overview with reference to the Yemen epidemic | |
| P478 | volume | 13 |
Search more.